Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201308040 Principal Investigator: Michalski, Jeff
Title: PARTIQoL: Prostate Advanced Radiation Technologies Investigating Quality of Life; A Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
Description: The purpose of this trial will be to compare two types of therapies that are both approved by the U.S. Food and Drug Administration for your type of cancer to see if one is better for treating it. In particular, we are studying whether men being treated for prostate cancer have the same amount of s...MORE
___________________________________________________________________________________________________
 Number: RTOG 0924 Principal Investigator: Michalski, Jeff
Title: Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Description: The purpose of this study is to compare the effects of hormone therapy (androgen deprivation) and radiation therapy to the prostate gland and seminal vesicles with hormone therapy and radiation therapy to the whole pelvic body area on you and your prostate cancer to find out which is better. There ...MORE
___________________________________________________________________________________________________
 Number: RTOG 0815 Principal Investigator: Michalski, Jeff
Title: A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy For Patients With Intermediate-Risk Prostate Cancer
Description: The purpose of this study is to compare the effects of dose-escalated radiation therapy with or without hormone therapy on prostate cancer. Prior studies have suggested possible advantages to the administration of hormonal therapy with radiation. However, those studies were performed with radiation...MORE
___________________________________________________________________________________________________
 Number: CTSU S1216 Principal Investigator: Picus, Joel
Title: A Phase III Randomized Trial Comparing Androgen Deprivaton Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer (S1216)
Description: The purpose of this study is to find out what effects there are to adding the new investigational drug TAK-700 to standard hormone therapy which is used to treat prostate cancer as compared to the standard of hormone therapy alone....MORE
___________________________________________________________________________________________________
 Number: CALGB A031201 Principal Investigator: Picus, Joel
Title: Phase III Trial of Enzalutamide (NSC # 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer
Description: The purpose of this study is to compare the effects, good and/or bad, of abiraterone, prednisone, and enzalutamide with enzalutamide alone on patients who have prostate cancer to find out which is better....MORE
___________________________________________________________________________________________________
 Number: 201312129 Principal Investigator: Gay, Hiram
Title: A Randomized Open-Label Phase IIa Study Evaluating Quantified Bone Scan Response Following Treatment with Radium-223 Dichloride Alone or in Combination with Abiraterone Acetate or Enzalutamide in Subjects with Castration-Resistant Prostate Cancer Who Have Bone Metastases (Protocol 16544)
Description: The main goal of this study is to use bone scans to measure the amount of response in prostate cancer that has spread to bones, after 24 weeks of treatment with one of 3 possible study treatments. The method of measuring the amount of response in bones is not commonly used, so this study will prov...MORE
___________________________________________________________________________________________________
 Number: 201409106 Principal Investigator: Michalski, Jeff
Title: PARTIQoL (Prostate Advanced Radiation Technologies Investigating Quality of Life) Registry: A Companion to Phase III Randomized PARTIQoL Clinical
Description: This is a research study. We invite you to participate in this research study because you have prostate cancer and you had declined participation in the main research study that sought to compare Intensity Modulated Radiation Therapy (IMRT) and Proton Beam Therapy (PBT) for the treatment of prosta...MORE
___________________________________________________________________________________________________
 Number: 201108010 Principal Investigator: Wilson, Richard
Title: Germline Sequencing for Aggressive Prostate Carcinoma
___________________________________________________________________________________________________
 Number: 201105154 Principal Investigator: Drake, Bettina
Title: Obesity and Vitamin D Related Effects on Prostate Cancer Recurrence
___________________________________________________________________________________________________